Aaron Klaiber
Doctoral researcher at the University of Basel
Key Impact
He appears as an author on multiple controlled human psychedelic studies spanning DMT, mescaline, MDMA, LSD, and psilocybin, suggesting a substantial role in contemporary psychopharmacology research.
Background & Research
Aaron Klaiber is a doctoral researcher affiliated with the University of Basel’s psychiatry/psychology research environment. He appears as a co-author on several recent controlled clinical studies of classic psychedelics and MDMA in healthy participants, including work on DMT, mescaline, LSD, and MDMA combinations. His publication trail indicates involvement in experimental psychopharmacology and human psychedelic research at the University of Basel.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →